SQZB Stock - SQZ Biotechnologies Company
Unlock GoAI Insights for SQZB
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $21.03M | $27.10M | $21.00M | $20.11M | $12.67M |
| Gross Profit | $9.79M | $16.07M | $21.00M | $20.11M | $12.67M |
| Gross Margin | 46.6% | 59.3% | 100.0% | 100.0% | 100.0% |
| Operating Income | $-80,684,000 | $-68,769,000 | $-51,058,000 | $-34,265,000 | $-20,404,000 |
| Net Income | $-79,464,000 | $-68,741,000 | $-50,521,000 | $-32,202,000 | $-20,234,000 |
| Net Margin | -377.9% | -253.7% | -240.6% | -160.1% | -159.7% |
| EPS | $-2.76 | $-2.49 | $-2.04 | $-1.31 | $-0.82 |
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Visit WebsiteEarnings History & Surprises
SQZBEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 4, 2025 | — | — | — | — |
Q2 2025 | May 29, 2025 | — | — | — | — |
Q1 2025 | Mar 28, 2025 | — | — | — | — |
Q4 2024 | Nov 18, 2024 | $-4.55 | — | — | — |
Q3 2024 | Sep 24, 2024 | $-4.55 | — | — | — |
Q2 2024 | Jun 13, 2024 | — | — | — | — |
Q1 2024 | Feb 29, 2024 | $-0.46 | — | — | — |
Q4 2023 | Nov 8, 2023 | $-0.66 | $-0.54 | +18.2% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-0.60 | $-0.57 | +5.0% | ✓ BEAT |
Q2 2023 | May 10, 2023 | $-0.51 | $-0.60 | -17.9% | ✗ MISS |
Q1 2023 | Mar 22, 2023 | $-0.80 | $-0.46 | +42.8% | ✓ BEAT |
Q3 2022 | Sep 29, 2022 | $-0.82 | $-0.77 | +5.7% | ✓ BEAT |
Q2 2022 | Jun 29, 2022 | $-0.76 | $-0.78 | -3.0% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | — | $-0.75 | — | — |
Q4 2021 | Dec 30, 2021 | $-0.69 | $-0.42 | +38.7% | ✓ BEAT |
Q3 2021 | Sep 29, 2021 | — | $-0.80 | — | — |
Latest News
Frequently Asked Questions about SQZB
What is SQZB's current stock price?
What is the analyst price target for SQZB?
What sector is SQZ Biotechnologies Company in?
What is SQZB's market cap?
Does SQZB pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to SQZB for comparison